New visual processing unit (VPU) with asymmetric waveforms for Retinitis Pigmentosa
Phase-Based Progress Estimates
Effectiveness
Safety
University of Michigan, Ann Arbor, MIRetinitis PigmentosaNew visual processing unit (VPU) with asymmetric waveforms - Device
Study Summary
This trial will test new ways to stimulate and train the retina in order to improve the vision of those with retinal prosthesis.
Eligible Conditions
- Retinitis Pigmentosa
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: Baseline, 8 hours
Baseline, 8 hours
Change in shape perception
Percent change in stimulus thresholds
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Retinal stimulation
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: New visual processing unit (VPU) with asymmetric waveforms · No Placebo Group · N/A
Retinal stimulationExperimental Group · 2 Interventions: New visual processing unit (VPU) with asymmetric waveforms, New VPU with bipolar stimulation · Intervention Types: Device, Device
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 8 hours
Who is running the clinical trial?
University of MichiganLead Sponsor
1,647 Previous Clinical Trials
6,420,427 Total Patients Enrolled
3 Trials studying Retinitis Pigmentosa
555 Patients Enrolled for Retinitis Pigmentosa
National Eye Institute (NEI)NIH
520 Previous Clinical Trials
1,075,375 Total Patients Enrolled
22 Trials studying Retinitis Pigmentosa
14,334 Patients Enrolled for Retinitis Pigmentosa
James WeilandPrincipal Investigator - University of Michigan
University of Michigan
Eligibility Criteria
Age 25 - 89 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You must have an Argus II Retinal Prosthesis implanted.
Who else is applying?
What state do they live in?
Texas | 100.0% |
How old are they?
18 - 65 | 100.0% |
What portion of applicants met pre-screening criteria?
Met criteria | 100.0% |